JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

B2065 Vitamin D3

Summary: Fat-soluble secosteroids

insoluble in H2O; ≥51.6 mg/mL
B1387 (-)-Blebbistatin
9 Citation

Target: Myosin II ATPases

Summary: non-muscle myosin II inhibitor

insoluble in EtOH; insoluble in H2O; ≥14.62 mg/mL
B1755 Fidaxomicin
10 Citation

Summary: macrocyclic antibiotic

≥35.27 mg/mL
A2513 G418 Sulfate (Geneticin, G-418)
6 Citation

Target: Ribosomes

Summary: Geneticin, G-418 Sulfate

insoluble in EtOH; insoluble in DMSO; ≥64.6 mg/mL
A8174 Cathepsin G Inhibitor I

Target: Cathepsins

Summary: Cathepsin G inhibitor

≥10.35 mg/mL
A3007 ABT-263 (Navitoclax)
57 Citation

Target: Bcl-2|Bcl-w

Summary: Bcl-2 family inhibitor

≥48.73 mg/mL
A3011 CHIR-99021 (CT99021)
26 Citation

Target: GSK-3

Summary: GSK-3 inhibitor

≥23.27 mg/mL
A4002 IU1
1 Citation

Summary: Usp14 inhibitor

insoluble in H2O; ≥10.9 mg/mL
A1903 E 64d
8 Citation

Summary: Cysteine protease inhibitor

insoluble in H2O; ≥17.12 mg/mL
A4334 Avanafil
1 Citation

Target: Phosphodiesterases (PDEs)

Summary: PDE5 inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL